4.2 Article

Antiviral Resistance in Influenza Viruses Laboratory Testing

Journal

CLINICS IN LABORATORY MEDICINE
Volume 34, Issue 2, Pages 387-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cll.2014.02.010

Keywords

Pyrosequencing; Matrix gene; Neuraminidase; Inhibition assays

Ask authors/readers for more resources

Influenza continues to be a significant health care issue. Although vaccination is the major line of defense, antiviral drugs play an important role in prophylaxis and disease management. Approved drugs for influenza are currently limited to those that target the viral matrix protein or neuraminidase enzyme. Resistance-associated sequence changes in the genes encoding these proteins have been extensively studied. Available methods for genotypic and phenotypic antiviral susceptibility testing have expanded and are being further developed and improved. The sporadic emergence of drug-resistant variants and the global spread of resistant strains have demonstrated the ongoing need for vigilant testing and surveillance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available